IL130071A0 - Use of equilenin as an antioxidant - Google Patents

Use of equilenin as an antioxidant

Info

Publication number
IL130071A0
IL130071A0 IL13007197A IL13007197A IL130071A0 IL 130071 A0 IL130071 A0 IL 130071A0 IL 13007197 A IL13007197 A IL 13007197A IL 13007197 A IL13007197 A IL 13007197A IL 130071 A0 IL130071 A0 IL 130071A0
Authority
IL
Israel
Prior art keywords
equilenin
antioxidant
Prior art date
Application number
IL13007197A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL130071A0 publication Critical patent/IL130071A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13007197A 1996-12-10 1997-12-05 Use of equilenin as an antioxidant IL130071A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76257996A 1996-12-10 1996-12-10
PCT/US1997/022154 WO1998025626A1 (fr) 1996-12-10 1997-12-05 Utilisation de l'equilenine comme antioxydant

Publications (1)

Publication Number Publication Date
IL130071A0 true IL130071A0 (en) 2000-02-29

Family

ID=25065472

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13007197A IL130071A0 (en) 1996-12-10 1997-12-05 Use of equilenin as an antioxidant

Country Status (14)

Country Link
EP (1) EP0944391A1 (fr)
JP (1) JP2001506628A (fr)
KR (1) KR20000069412A (fr)
CN (1) CN1239892A (fr)
AR (1) AR010344A1 (fr)
AU (1) AU743586B2 (fr)
BR (1) BR9714384A (fr)
CA (1) CA2272087A1 (fr)
HU (1) HUP0000569A3 (fr)
IL (1) IL130071A0 (fr)
NZ (1) NZ336343A (fr)
TW (1) TW466115B (fr)
WO (1) WO1998025626A1 (fr)
ZA (1) ZA9711052B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271221B1 (en) * 1996-12-10 2001-08-07 American Home Products Corporation Use of equilenin as an antioxidant
DE19915576A1 (de) * 1999-03-30 2000-10-05 Jenapharm Gmbh Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US20030139458A1 (en) * 2001-12-10 2003-07-24 Yansheng Du Treatment of neurodegenerative and cardiovascular disorders
CN108958639B (zh) 2017-05-19 2021-07-06 华邦电子股份有限公司 快闪存储器存储装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4937238A (en) * 1986-03-04 1990-06-26 The Board Of Regents Of The University Of Nebraska Prevention of mammary carcinoma
EP0240717A3 (fr) * 1986-03-04 1990-05-16 Board of Regents of the University of Nebraska Prévention du carcinome du sein
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin

Also Published As

Publication number Publication date
WO1998025626A1 (fr) 1998-06-18
TW466115B (en) 2001-12-01
AU5370798A (en) 1998-07-03
EP0944391A1 (fr) 1999-09-29
NZ336343A (en) 2000-11-24
JP2001506628A (ja) 2001-05-22
KR20000069412A (ko) 2000-11-25
CN1239892A (zh) 1999-12-29
CA2272087A1 (fr) 1998-06-18
AU743586B2 (en) 2002-01-31
HUP0000569A3 (en) 2000-11-28
ZA9711052B (en) 1999-06-09
AR010344A1 (es) 2000-06-07
BR9714384A (pt) 2000-05-16
HUP0000569A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
IL129423A0 (en) Improved preparation for use as contrast agent
GB9600426D0 (en) Compositions
PL332118A1 (en) Remineralisable compositions
IL128718A0 (en) Naaldase compositions
IL130330A0 (en) Endo-ectoparasiticidal compositions
EP0897264A4 (fr) Composition naturelle antioxydante
EP0960191A4 (fr) Compositions et procedes permettant l'utilisation de defensine
ZA9710601B (en) Novel formulation
GB9624540D0 (en) Compositions
GB9623562D0 (en) Sachet-packaged compositions
GB9620504D0 (en) Compositions
HRP970569A2 (en) Fharmaceutical compositions
IL130071A0 (en) Use of equilenin as an antioxidant
GB2308812B (en) Antiseptic compositions
HUP9603329A3 (en) Use of 8,9-dehydroestrone as an antioxidant
IL130070A0 (en) Use of 17beta-dihydroequilenin as an antioxidant
GB9620503D0 (en) Compositions
GB9615628D0 (en) Formulation
GB9611365D0 (en) Compositions
ZA9711053B (en) Antioxidant Antioxidant
GB9600545D0 (en) Compositions
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
IL117729A0 (en) Use of nebivolol as an anti-atherogenic agent
EP0907318A4 (fr) Compose antioxydant
TW358610U (en) Improvement of inter-com